chr2-226795333-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005544.3(IRS1):c.3406G>A(p.Glu1136Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000192 in 1,613,394 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005544.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRS1 | NM_005544.3 | c.3406G>A | p.Glu1136Lys | missense_variant | 1/2 | ENST00000305123.6 | NP_005535.1 | |
IRS1 | XM_047444223.1 | c.3406G>A | p.Glu1136Lys | missense_variant | 1/2 | XP_047300179.1 | ||
IRS1 | XM_047444224.1 | c.3406G>A | p.Glu1136Lys | missense_variant | 1/2 | XP_047300180.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRS1 | ENST00000305123.6 | c.3406G>A | p.Glu1136Lys | missense_variant | 1/2 | 1 | NM_005544.3 | ENSP00000304895 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000480 AC: 73AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000248 AC: 62AN: 250132Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135416
GnomAD4 exome AF: 0.000162 AC: 236AN: 1461062Hom.: 1 Cov.: 42 AF XY: 0.000155 AC XY: 113AN XY: 726836
GnomAD4 genome AF: 0.000486 AC: 74AN: 152332Hom.: 0 Cov.: 33 AF XY: 0.000510 AC XY: 38AN XY: 74494
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The IRS1 p.Glu1136Lys variant was identified in the literature somatically in a soft tissue sarcoma tumor from a cohort of 207 sarcoma patients (Barretina_2010_PMID:20601955). The variant was identified in dbSNP (ID: rs200142054) and LOVD 3.0 (classified as likely benign); the variant was not identified in ClinVar. The variant was identified in control databases in 73 of 281490 chromosomes at a frequency of 0.0002593 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 49 of 24882 chromosomes (freq: 0.001969), Latino in 16 of 35412 chromosomes (freq: 0.000452), Other in 2 of 7196 chromosomes (freq: 0.000278), East Asian in 1 of 19918 chromosomes (freq: 0.00005), European (Finnish) in 1 of 24510 chromosomes (freq: 0.000041), South Asian in 1 of 30604 chromosomes (freq: 0.000033) and European (non-Finnish) in 3 of 128634 chromosomes (freq: 0.000023), but was not observed in the Ashkenazi Jewish population. The p.Glu1136 residue is conserved in mammals but not in more distantly related organisms however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
IRS1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 10, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at